Scientific paper - Original scientific paper
Incremental cost-effectiveness pharmacoeconomic assessment of hepatitis C virus therapy: an approach for less wealthy members of the common market

Mance, Diana; Mance, Davor; Vitezić, Dinko (2016)
Cite this document...

Mance, D., Mance, D. & Vitezić, D. (2016). Incremental cost-effectiveness pharmacoeconomic assessment of hepatitis C virus therapy: an approach for less wealthy members of the common market. Croatian medical journal, 57. (6), 582-590. doi: 10.3325/cmj.2016.57.582

Mance, Diana, et al. "Incremental cost-effectiveness pharmacoeconomic assessment of hepatitis C virus therapy: an approach for less wealthy members of the common market." Croatian medical journal, vol. 57, no. 6, 2016, pp. 582-590. https://doi.org/10.3325/cmj.2016.57.582

Mance, Diana, Davor Mance and Dinko Vitezić. "Incremental cost-effectiveness pharmacoeconomic assessment of hepatitis C virus therapy: an approach for less wealthy members of the common market." Croatian medical journal 57, no. 6 (2016): 582-590. https://doi.org/10.3325/cmj.2016.57.582

Mance, D., Mance, D. and Vitezić, D. (2016) 'Incremental cost-effectiveness pharmacoeconomic assessment of hepatitis C virus therapy: an approach for less wealthy members of the common market', Croatian medical journal, 57(6), pp. 582-590. doi: 10.3325/cmj.2016.57.582

Mance D, Mance D, Vitezić D. Incremental cost-effectiveness pharmacoeconomic assessment of hepatitis C virus therapy: an approach for less wealthy members of the common market. Croatian medical journal [Internet]. 2016 December 15 [cited 2019 May 21];57(6):582-590. doi: 10.3325/cmj.2016.57.582

D. Mance, D. Mance and D. Vitezić, "Incremental cost-effectiveness pharmacoeconomic assessment of hepatitis C virus therapy: an approach for less wealthy members of the common market", Croatian medical journal, vol. 57, no. 6, pp. 582-590, December 2016. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:097911. [Accessed: 21 May 2019]